Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.
Sponsor: AUSL Romagna Rimini
Summary
Study design: single arm, interventional and multicenter study. The objectives are evaluate Safety and efficacy of TAVI in Department of Cardiology without on site cardiac Surgery for symptomatic severe aortic valve stenosis by expert operator team, in patients with prohibitive surgical risk. For the pilot phase, 20 patients will be enrolled. For whole study, all consecutive patients undergoing TAVI in center without CS on site will be enrolled to reach a number of about 200 patients.
Key Details
Gender
All
Age Range
75 Years - 120 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2023-05-01
Completion Date
2026-04
Last Updated
2025-02-21
Healthy Volunteers
No
Conditions
Interventions
Transfemoral transcatheter aortic valve implementation
ranscatheter aortic valve implantation, a percutaneous treatment for severe aortic valve stenosis, is increasingly performed worldwide. The pacemaker should be able to perform overdrive pacing which is essential to reduce cardiac output and transvalvular blood flow which are critical during balloon aortic valvuloplasty and valve deployment of the balloon- expandable valve. Minor adjustment may be needed for ideal positioning, but importantly this has to be done before valve implantation
Locations (4)
Ospedale Generale Regionale F Miulli
Acquaviva delle Fonti, Bari, Italy
AUSL Romagna Morgagni - Pierantoni Hospital
Forlì, Emilia-Romagna, Italy
Ospedale Santa Maria della Croci
Ravenna, Italy
Hospital del Mar
Barcelona, Spain